Halozyme Therapeutics shares owned by Aubrey Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Aubrey Capital Management
from 13F filings
Historical chart of Aubrey Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Aubrey Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Aubrey Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $422k | 11k | 37.67 |
| 2023-12-31 | $414k | 11k | 36.96 |
| 2023-09-30 | $404k | 11k | 36.08 |
| 2023-06-30 | $404k | 11k | 36.07 |
| 2023-03-31 | $428k | 11k | 38.19 |
| 2022-12-31 | $637k | 11k | 56.90 |
| 2022-09-30 | $443k | 11k | 39.54 |
| 2022-06-30 | $493k | 11k | 44.00 |
| 2022-03-31 | $447k | 11k | 39.91 |
| 2021-12-31 | $358k | 8.9k | 40.21 |
| 2021-09-30 | $362k | 8.9k | 40.68 |
| 2021-06-30 | $485k | 11k | 45.41 |
| 2021-03-31 | $445k | 11k | 41.69 |
| 2020-12-31 | $301k | 7.0k | 42.71 |